NeuroSense previews Phase IIb trial plans for oral ALS drug
NeuroSense CEO Alon Ben-Noon reveals the target patient population and outcome measures of a planned Phase IIb ALS trial to…
By
Middle East & Africa
Latest in
Middle East & Africa
Oramed ends subject enrolment in Phase II trial of oral insulin for NASH
The company anticipates reporting topline data from the trial in the second half of this year.
Major depressive disorder: where are the top clinical trial locations?
There is an emerging trend of specific sponsor types running MDD trials, as well as such studies embracing decentralisation.
By
IGM Biosciences progresses Covid-19 antibody to two clinical trials
Two clinical trials will be conducted in the US and South Africa to assess intranasal doses of IGM-6268.
Can-Fite enrols first subject in Phase IIb NASH trial
The trial will recruit 140 patients with biopsy-confirmed NASH.
The dynamics of clinical research in Africa: 2016-21
Over the last five years, the conduct of clinical research in Africa has shown a steady increase, but the level…
By
SAHPRA grants approval to begin trial of PaxMedica’s long Covid-19 therapy
The trial will assess the tolerability, safety, efficacy and PK of two varying doses of suramin in adult LCS patients.
The Middle East has seen the largest growth in infectious disease related trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
By